Presbyopia

• FDA approval · 2023-10-17
  FDA Approved: QLOSI — Original Application (Orasis Pharmaceuticals, Inc.)

  FDA approved QLOSI (pilocarpine hydrochloride) from Orasis Pharmaceuticals in its original NDA (NDA217836) for presbyopia.

• FDA approval · 2023-03-28
  FDA Approved: VUITY — Supplemental Application (AbbVie Inc.)

  FDA approved a supplemental application for VUITY (pilocarpine hydrochloride) submitted by AbbVie.

• FDA approval · 2023-03-08
  FDA Approved: VUITY — Supplemental Application (AbbVie Inc.)

  FDA approved a supplemental application for VUITY (pilocarpine hydrochloride) from AbbVie Inc., indicating an approved modification to the p…

• FDA approval · 2022-08-16
  FDA Approved: VUITY — Supplemental Application (AbbVie Inc.)

  FDA approved a supplemental application for VUITY (pilocarpine hydrochloride) from AbbVie Inc., expanding the product's indication for the t…

• FDA approval · 2021-10-28
  FDA Approved: VUITY — Original Application (AbbVie Inc.)

  The FDA approved VUITY (pilocarpine hydrochloride) from AbbVie in an Original Application for improving near vision in adults with presbyopi…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.